Deadly Outbreak Puts Compounded Drugs In FDA's Crosshairs
A deadly meningitis outbreak connected to steroids made by a Massachusetts compound pharmacy could drive the U.S. Food and Drug Administration to crack down on compounded medications, a product it has...To view the full article, register now.
Already a subscriber? Click here to view full article